Björn Ringdahl

768 total citations
65 papers, 533 citations indexed

About

Björn Ringdahl is a scholar working on Organic Chemistry, Molecular Biology and Spectroscopy. According to data from OpenAlex, Björn Ringdahl has authored 65 papers receiving a total of 533 indexed citations (citations by other indexed papers that have themselves been cited), including 30 papers in Organic Chemistry, 29 papers in Molecular Biology and 18 papers in Spectroscopy. Recurrent topics in Björn Ringdahl's work include Receptor Mechanisms and Signaling (24 papers), Molecular spectroscopy and chirality (14 papers) and Neuroscience and Neuropharmacology Research (10 papers). Björn Ringdahl is often cited by papers focused on Receptor Mechanisms and Signaling (24 papers), Molecular spectroscopy and chirality (14 papers) and Neuroscience and Neuropharmacology Research (10 papers). Björn Ringdahl collaborates with scholars based in United States, Sweden and Germany. Björn Ringdahl's co-authors include Donald J. Jenden, Richard Dahlbom, Bahram Resul, J. Cymerman Craig, Uli Hacksell, Rosalind P. K. Chan, D J Jenden, Michael Newton, Margareth Roch and Maurice Shamma and has published in prestigious journals such as Analytical Biochemistry, Journal of Medicinal Chemistry and Journal of Pharmacology and Experimental Therapeutics.

In The Last Decade

Björn Ringdahl

64 papers receiving 497 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Björn Ringdahl United States 13 327 211 172 97 49 65 533
H. Bruderer Switzerland 14 220 0.7× 230 1.1× 255 1.5× 95 1.0× 57 1.2× 21 685
Piero Angeli Italy 14 365 1.1× 196 0.9× 179 1.0× 73 0.8× 31 0.6× 56 593
Nithiananda Chatterjie United States 15 258 0.8× 122 0.6× 133 0.8× 39 0.4× 29 0.6× 39 560
Robert M. DeMarinis United States 17 452 1.4× 285 1.4× 214 1.2× 44 0.5× 35 0.7× 41 750
H. WIKSTROEM Sweden 14 377 1.2× 342 1.6× 190 1.1× 22 0.2× 44 0.9× 23 604
Vittorio Vecchietti Italy 11 312 1.0× 215 1.0× 173 1.0× 32 0.3× 16 0.3× 26 503
Edmund C. Kornfeld United States 13 231 0.7× 181 0.9× 400 2.3× 54 0.6× 29 0.6× 30 777
Linda L. Coughenour United States 18 394 1.2× 352 1.7× 267 1.6× 73 0.8× 25 0.5× 29 806
F. Troxler Japan 14 280 0.9× 201 1.0× 507 2.9× 90 0.9× 53 1.1× 38 902
P. Narasimha Rao United States 12 188 0.6× 91 0.4× 111 0.6× 27 0.3× 50 1.0× 43 572

Countries citing papers authored by Björn Ringdahl

Since Specialization
Citations

This map shows the geographic impact of Björn Ringdahl's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Björn Ringdahl with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Björn Ringdahl more than expected).

Fields of papers citing papers by Björn Ringdahl

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Björn Ringdahl. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Björn Ringdahl. The network helps show where Björn Ringdahl may publish in the future.

Co-authorship network of co-authors of Björn Ringdahl

This figure shows the co-authorship network connecting the top 25 collaborators of Björn Ringdahl. A scholar is included among the top collaborators of Björn Ringdahl based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Björn Ringdahl. Björn Ringdahl is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ringdahl, Björn, et al.. (1990). .beta.-Lactam analogs of oxotremorine. 3- and 4-Methyl-substituted 2-azetidinones. Journal of Medicinal Chemistry. 33(2). 580–584. 35 indexed citations
2.
Vargas, Hugo M. & Björn Ringdahl. (1990). Centrally active antimuscarinic analogs of oxotremorine selectively block physostigmine-induced hypertension, but not peripheral muscarinic vasodepression.. Journal of Pharmacology and Experimental Therapeutics. 253(1). 165–170. 5 indexed citations
3.
Vargas, Hugo M. & Björn Ringdahl. (1990). Antimuscarinic potency and functional selectivity of oxotremorine analogs at muscarinic receptor subtypes in the rat. Life Sciences. 47(22). 2065–2073. 1 indexed citations
4.
Mellin, Charlotta, Hugo M. Vargas, & Björn Ringdahl. (1989). Dimethylsulfonium analogs of the muscarinic agent McN-A-343: [4-[[N-(3- or 4-halophenyl)carbamoyl]oxy]-2-butynyl]dimethylsulfonium perchlorates. Journal of Medicinal Chemistry. 32(7). 1590–1593. 10 indexed citations
5.
Ringdahl, Björn, et al.. (1989). Conformationally restricted analogs of the muscarinic agent N-methyl-N-(1-methyl-4-pyrrolidino-2-butynyl)acetamide. Journal of Medicinal Chemistry. 32(4). 863–869. 10 indexed citations
6.
Ringdahl, Björn, Margareth Roch, & Donald J. Jenden. (1988). Tertiary 3- and 4-haloalkylamine analogs of oxotremorine as prodrugs of potent muscarinic agonists. Journal of Medicinal Chemistry. 31(1). 160–164. 7 indexed citations
7.
Ringdahl, Björn. (1988). Dimethylsulfonium and thiolanium analogs of the muscarinic agent oxotremorine. Journal of Medicinal Chemistry. 31(1). 164–168. 2 indexed citations
8.
Ringdahl, Björn. (1988). 5-Methyl-2-pyrrolidone analogs of oxotremorine as selective muscarinic agonists. Journal of Medicinal Chemistry. 31(3). 683–688. 5 indexed citations
9.
10.
Ringdahl, Björn & Donald J. Jenden. (1987). Kinetics of solvolysis and muscarinic actions of a (2-bromoethyl)methylamino analog of oxotremorine. Journal of Medicinal Chemistry. 30(5). 852–854. 1 indexed citations
11.
Ringdahl, Björn & D J Jenden. (1987). Muscarinic actions of an N-methyl-N-2-bromoethylamino analog of oxotremorine (BR 401) in the mouse.. Journal of Pharmacology and Experimental Therapeutics. 240(2). 370–375. 3 indexed citations
12.
Ringdahl, Björn, et al.. (1987). Muscarinic and antimuscarinic activity of acetamides related to oxotremorine in the guinea pig urinary bladder.. Journal of Pharmacology and Experimental Therapeutics. 240(3). 789–794. 9 indexed citations
13.
Ringdahl, Björn. (1985). Structural requirements for muscarinic receptor occupation and receptor activation by oxotremorine analogs in the guinea-pig ileum.. Journal of Pharmacology and Experimental Therapeutics. 232(1). 67–73. 12 indexed citations
14.
15.
Ringdahl, Björn & Donald J. Jenden. (1983). Affinity, efficacy, and stereoselectivity of oxotremorine analogues for muscarinic receptors in the isolated guinea pig ileum.. Molecular Pharmacology. 23(1). 17–25. 20 indexed citations
16.
Ringdahl, Björn, et al.. (1982). Muscarinic activity and receptor binding of the enantiomers of aceclidine and its methiodide.. Molecular Pharmacology. 21(3). 594–599. 17 indexed citations
17.
Resul, Bahram, Richard Dahlbom, Björn Ringdahl, & Donald J. Jenden. (1982). ChemInform Abstract: N‐ALKYL‐N‐(4‐TERT‐AMINO‐1‐METHYL‐2‐BUTYNYL)CARBOXAMIDES, A NEW CLASS OF POTENT OXOTREMORINE ANTAGONISTS. Chemischer Informationsdienst. 13(48). 6 indexed citations
18.
Ringdahl, Björn & Richard Dahlbom. (1979). Acetylene compounds of potential pharmacological value. XXIX. Stereoselectivity of N-(1-alkyl-4-pyrrolidino-2-butynyl)-substituted 2-pyrrolidones and succinimides as oxotremorine antagonists.. PubMed. 16(1). 13–20. 1 indexed citations
19.
Ringdahl, Björn, Bahram Resul, & Richard Dahlbom. (1979). Stereoselectivity of some oxotremorine antagonists containing two chiral centres. Journal of Pharmacy and Pharmacology. 31(1). 837–839. 4 indexed citations
20.
Ringdahl, Björn & Richard Dahlbom. (1978). Acetylene compounds of potential pharmacological value. XXVII. Stereoselectivity of oxotremorine antagonists containing a chiral pyrrolidine group.. PubMed. 15(4). 255–63. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by H. Bruderer Breakdown of academic impact, for papers by Piero Angeli Breakdown of academic impact, for papers by Nithiananda Chatterjie Breakdown of academic impact, for papers by Robert M. DeMarinis Breakdown of academic impact, for papers by H. WIKSTROEM Breakdown of academic impact, for papers by Vittorio Vecchietti Breakdown of academic impact, for papers by Edmund C. Kornfeld Breakdown of academic impact, for papers by Linda L. Coughenour Breakdown of academic impact, for papers by F. Troxler Breakdown of academic impact, for papers by P. Narasimha Rao
Rankless by CCL
2026